Federal Budget 2022: What’s in it to accelerate Australia’s innovation agenda?
We discuss the key measures in Australia’s 2022-23 federal budget that could help drive innovation, research commercialisation and business growth.
Read more
Amanda Stark, Janelle Borham named Patent Stars for 2022 by Managing IP
Griffith Hack principals Amanda Stark and Janelle Borham have been named as Patent Stars in the IP STARS 2022 rankings by Managing IP.
Read more
Reversal of fortune – Full Court decides that an artificial intelligence is not an “inventor”
Anthony Selleck reviews the decision in Commissioner of Patents v Thaler [2022] FCAFC 62 which reverses an earlier ruling that artificial intelligence can be an “inventor” for the purposes of the Australian Patents Act 1990.
Read more
AI and Digital Capability Centre Grants: What you need to know before applying
Applications are now open for Artificial Intelligence (AI) and Digital Capability Centre Grants of up to $11 million. Here’s what you need to know before applying.
Read more
From idea to inception and beyond: Important learnings from female biotech founders
Female biotech founders took centre-stage at AusBiotech 2021 with the leaders of some of Australia’s most innovative start-ups coming together to discuss their experiences in the commercial scientific world.
Read more
Saving grace: Options if you disclose your invention without a patent application
Publicly disclosing new technology before a patent application has been filed can jeopardise patent coverage – but there are options available to you in the event of disclosure.
Read more
Virus filtration patent gets clean bill of health
In a recent decision of the Australian Patent Office, a patent application directed to a membrane for filtering biological products was upheld following opposition.
Read more
Jacqui Thomas, Daniel Hsieh register as patent attorneys in Australia and New Zealand
Griffith Hack is pleased to announce that Jacqui Thomas and Daniel Hsieh are now registered patent attorneys in Australia and New Zealand.
Read more
Awkward first dates:
How is patent term extension calculated when a patent covers more than one pharmaceutical substance with regulatory approval?
Bayer Pharma Aktiengesellschaft [2022] APO
Read more
Extending the 12-month grace period for filing patent applications – what you need to know
Can the 12-month grace period for filing your patent application be extended? Yes, it can – but subject to the facts.
Read more
Ben Dziekan wins IPTA’s prestigious Edward Waters Prize for 2021
Melbourne-based patent attorney Ben Dziekan has been named co-winner of the Institute of Patent and Trade Mark Attorneys of Australia’s prestigious Edwards Waters Prize for 2021.
Read more
Your Australian patent application has been opposed – what next?
Australia’s pre‑grant opposition proceedings are playing a more significant role in the strategies of patentees and challengers. So what should a patent owner do when faced with an opposition in Australia?
Read more
Why are embryonic stem cells not able to be patented in Australia?
Despite not being specifically excluded under s18 of the Australian Patents Act, technology utilising embryonic stem cells is not able to be patented in Australia. Why is this so?
Read more
Recent progress in psychedelic therapies
With increasing awareness of the prevalence of mental ill-health in society, we analyse promising psychedelic therapies that have not yet entered mainstream.
Read more
Spotlight Series: Regenerative Medicine – Part 1
The first in a five-part series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.
Read more
Innovation patents: options for challenging problematic cases
What are your options if you identify an innovation patent that affects your freedom to operate?
Read more
Patent drafting conventions fall foul of Australian Courts
In a recent opposition appeal decision of the Federal Court of Australia, an Australian patent application by Nalco Company was found invalid for lack of support and lack of clear enough and complete enough disclosure.
Read more
Revisiting how early is earliest? Further developments in Australian patent term extension law
Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947
Read more